OSEBX1 945,09+0,00 %
EQNR349,90+0,00 %
DNB281,10+0,00 %
MOWI202,20+0,00 %
Brent$102,06+0,78 %
Gold$4 714,80+0,44 %
USD/NOK9,3033+0,04 %
EUR/NOK10,9333+0,07 %
SPX7 365,12+1,46 %
NDX28 599,17+2,08 %
MARKETS CLOSED · LAST TRADE Thu 03:23 UTC
NC657

Nanollose Ltd

Textiles & Leather GoodsVerified
Score breakdown
Sentiment+30Missing signals-3
Quality breakdown
Key fields100Profile38Conclusion97AI synthesis40Observations3

Nanollose operates with a highly liquid capital structure, as evidenced by its current ratio of 2.07, indicating that its current assets significantly exceed its current liabilities. The company holds $617,320 in cash and equivalents, which is a substantial portion of its total assets of $747,790. However, its liquidity is offset by negative operating and free cash flows of -$1,098,550 and -$1,390,620, respectively, indicating ongoing cash burn [doc:HA-latest]. Profitability metrics are negative, with a return on equity of -3.5984 and a return on assets of -1.9076, both well below the industry median for the Textiles & Leather Goods sector. The company reported a net loss of $1,426,450 and an operating loss of $1,391,210, reflecting the challenges of scaling a novel biomaterials technology in a competitive market [doc:HA-latest]. The company's revenue of $11,950 is derived from its disclosed product lines, including Nullarbor fibers, MicroGel horticultural medium, and animal-free leather-like materials. However, the financial data does not provide a breakdown of revenue by segment or geography, making it difficult to assess concentration risk. The company's operations are primarily based in Australia, and there is no indication of significant international revenue exposure [doc:HA-latest]. Looking ahead, the company's growth trajectory is uncertain. The financial data does not include forward-looking revenue guidance or outlooks for the current or next fiscal year. The absence of positive revenue growth or margin improvement in the historical data suggests that the company is in an early-stage development phase, with a focus on R&D and market entry rather than profitability [doc:HA-latest]. Risk factors include the company's negative cash flows and net losses, which could lead to liquidity constraints if the company is unable to secure additional financing. The risk assessment indicates low dilution risk, with no immediate filing-based flags for dilution. However, the company's reliance on external financing to fund operations could increase dilution risk in the future [doc:HA-latest]. Recent events include the company's continued focus on commercializing its tree-free cellulose technology. The company has not disclosed any major recent filings or transcripts that would indicate significant changes in its business strategy or financial position. The company's ongoing R&D efforts and product development are likely to be key drivers of its future performance [doc:HA-latest].

Profile
CompanyNanollose Ltd
TickerNC6.AX
SectorConsumer Cyclicals
BusinessCyclical Consumer Products
Industry groupCyclical Consumer Products
IndustryTextiles & Leather Goods
AI analysis

Business. Nanollose Limited is an Australia-based biomaterials company that commercializes scalable technology to create fibers, fabrics, and other novel materials with minimal environmental impact using a fermentation process that produces tree-free cellulose from agricultural waste [doc:HA-latest].

Classification. Nanollose is classified under the Textiles & Leather Goods industry within the Cyclical Consumer Products business sector, with a classification confidence of 0.92 [doc:verified market data].

Nanollose operates with a highly liquid capital structure, as evidenced by its current ratio of 2.07, indicating that its current assets significantly exceed its current liabilities. The company holds $617,320 in cash and equivalents, which is a substantial portion of its total assets of $747,790. However, its liquidity is offset by negative operating and free cash flows of -$1,098,550 and -$1,390,620, respectively, indicating ongoing cash burn [doc:HA-latest]. Profitability metrics are negative, with a return on equity of -3.5984 and a return on assets of -1.9076, both well below the industry median for the Textiles & Leather Goods sector. The company reported a net loss of $1,426,450 and an operating loss of $1,391,210, reflecting the challenges of scaling a novel biomaterials technology in a competitive market [doc:HA-latest]. The company's revenue of $11,950 is derived from its disclosed product lines, including Nullarbor fibers, MicroGel horticultural medium, and animal-free leather-like materials. However, the financial data does not provide a breakdown of revenue by segment or geography, making it difficult to assess concentration risk. The company's operations are primarily based in Australia, and there is no indication of significant international revenue exposure [doc:HA-latest]. Looking ahead, the company's growth trajectory is uncertain. The financial data does not include forward-looking revenue guidance or outlooks for the current or next fiscal year. The absence of positive revenue growth or margin improvement in the historical data suggests that the company is in an early-stage development phase, with a focus on R&D and market entry rather than profitability [doc:HA-latest]. Risk factors include the company's negative cash flows and net losses, which could lead to liquidity constraints if the company is unable to secure additional financing. The risk assessment indicates low dilution risk, with no immediate filing-based flags for dilution. However, the company's reliance on external financing to fund operations could increase dilution risk in the future [doc:HA-latest]. Recent events include the company's continued focus on commercializing its tree-free cellulose technology. The company has not disclosed any major recent filings or transcripts that would indicate significant changes in its business strategy or financial position. The company's ongoing R&D efforts and product development are likely to be key drivers of its future performance [doc:HA-latest].
Key takeaways
  • Nanollose has a highly liquid balance sheet but is experiencing significant cash burn and negative profitability.
  • The company's return on equity and assets are well below industry medians, indicating poor capital efficiency.
  • Revenue concentration and geographic exposure are not disclosed, limiting visibility into business risk.
  • The company is in an early-stage development phase with no clear path to profitability.
  • Low dilution risk is currently reported, but the company's reliance on external financing could increase this risk.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue$11.9k
Gross profit
Operating income-$1.4M
Net income-$1.4M
R&D
SG&A
D&A
SBC
Operating cash flow-$1.1M
CapEx
Free cash flow-$1.4M
Total assets$747.8k
Total liabilities$351.4k
Total equity$396.4k
Cash & equivalents$617.3k
Long-term debt$13.1k
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$396.4k
Net cash$604.2k
Current ratio2.1
Debt/Equity0.0
ROA-1.9%
ROE-3.6%
Cash conversion77.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Textiles & Leather Goods · cohort 271 companies
MetricNC6Activity
Op margin-11641.9%4.3% medp25 -0.2% · p75 8.6%bottom quartile
Net margin-11936.8%2.3% medp25 -0.6% · p75 6.5%bottom quartile
Gross margin17.4% medp25 10.3% · p75 28.8%
CapEx / revenue-2.9% medp25 -6.0% · p75 -1.1%
Debt / equity3.0%46.3% medp25 9.2% · p75 99.3%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 05:00 UTC#51992c9d
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 05:01 UTCJob: a5833b6c